Clinical Trials Directory

Trials / Completed

CompletedNCT02929810

Sleep Extension and Blood Pressure

Lowering Blood Pressure by Sleep Extension: a Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Emerging evidence suggests that approximately 30% of the US adult population sleeps less than 7 hours per night, and those who do exhibit 20-52% enhanced risk to develop cardiovascular diseases and particularly hypertension. Since sleep curtailment is largely voluntary, sleep deficiency can be corrected and its detrimental health consequences potentially reversed. The purpose of the present proposal is to investigate the cardiovascular and metabolic effects of sleep extension in prehypertensive and stage 1 hypertensive subjects who report habitual short sleep.

Conditions

Interventions

TypeNameDescription
BEHAVIORALsleep extension
BEHAVIORALsleep maintenance

Timeline

Start date
2016-10-01
Primary completion
2023-09-07
Completion
2023-09-07
First posted
2016-10-11
Last updated
2024-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02929810. Inclusion in this directory is not an endorsement.

Sleep Extension and Blood Pressure (NCT02929810) · Clinical Trials Directory